search
Back to results

Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures

Primary Purpose

Febrile Seizures

Status
Completed
Phase
Phase 4
Locations
Egypt
Study Type
Interventional
Intervention
oral melatonin
oral diazepam
Sponsored by
Tanta University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Febrile Seizures focused on measuring Melatonin, Diazepam, recurrence, prophylaxis, Febrile convulsions

Eligibility Criteria

6 Months - 5 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children aged 6 months to 5 yrs .
  • Simple febrile seizures

Exclusion Criteria:

  • Complex febrile seizures
  • Child with history of neonatal seizure.
  • Afebrile seizures.
  • History of anticonvulsive therapy.
  • Children suffering from epilepsy.
  • Children with abnormal EEG.
  • Children with abnormal neurological examination.
  • Positive family history of epilepsy.

Sites / Locations

  • Tanta University, Faculty of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Melatonin

Diazepam

Arm Description

melatonin 0.3mg/kg/8 hours, orally. Given only during the febrile illness.

oral diazepam 1mg/kg/day divided into 3 doses. Given only during the febrile illness.

Outcomes

Primary Outcome Measures

recurrence of febrile seizures during febrile illness

Secondary Outcome Measures

side effect of medications reported in children

Full Information

First Posted
August 13, 2018
Last Updated
September 11, 2019
Sponsor
Tanta University
search

1. Study Identification

Unique Protocol Identification Number
NCT03631901
Brief Title
Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures
Official Title
Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures: Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
April 1, 2017 (Actual)
Primary Completion Date
September 1, 2018 (Actual)
Study Completion Date
September 1, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tanta University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To evaluate the efficacy of oral melatonin compared to oral diazepam for prevention of recurrent simple febrile seizures.
Detailed Description
To evaluate the efficacy of oral melatonin compared to oral diazepam for prevention of recurrence of simple febrile seizures in children aged 6 months to 5 years.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Febrile Seizures
Keywords
Melatonin, Diazepam, recurrence, prophylaxis, Febrile convulsions

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Melatonin
Arm Type
Active Comparator
Arm Description
melatonin 0.3mg/kg/8 hours, orally. Given only during the febrile illness.
Arm Title
Diazepam
Arm Type
Active Comparator
Arm Description
oral diazepam 1mg/kg/day divided into 3 doses. Given only during the febrile illness.
Intervention Type
Drug
Intervention Name(s)
oral melatonin
Intervention Description
Both melatonin and diazepam were given only during the febrile illness.
Intervention Type
Drug
Intervention Name(s)
oral diazepam
Intervention Description
Both melatonin and diazepam were given only during the febrile illness.
Primary Outcome Measure Information:
Title
recurrence of febrile seizures during febrile illness
Time Frame
6 months
Secondary Outcome Measure Information:
Title
side effect of medications reported in children
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children aged 6 months to 5 yrs . Simple febrile seizures Exclusion Criteria: Complex febrile seizures Child with history of neonatal seizure. Afebrile seizures. History of anticonvulsive therapy. Children suffering from epilepsy. Children with abnormal EEG. Children with abnormal neurological examination. Positive family history of epilepsy.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Amira Darwish
Organizational Affiliation
Tanta University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tanta University, Faculty of Medicine
City
Tanta
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Comparison Between Melatonin and Diazepam for Prevention of Recurrent Simple Febrile Seizures

We'll reach out to this number within 24 hrs